Corporate Overview
Incannex is a clinical-stage biopharmaceutical company leading the way in developing combination therapeutics that target underlying biological pathways associated with chronic conditions such as obstructive sleep apnea, rheumatoid arthritis, and generalized anxiety disorder. Our strategy is to advance novel therapies by leveraging evidence-based innovation with the potential to transform the lives of people suffering from these conditions.